Dual Role of Novel Ingenol Derivatives from Euphorbia tirucalli in HIV Replication: Inhibition of De Novo Infection and Activation of Viral LTR
出版年份 2014 全文链接
标题
Dual Role of Novel Ingenol Derivatives from Euphorbia tirucalli in HIV Replication: Inhibition of De Novo Infection and Activation of Viral LTR
作者
关键词
HIV, Cloning, T cells, HIV-1, HIV infections, Cytometry, Viral replication, Viral persistence and latency
出版物
PLoS One
Volume 9, Issue 5, Pages e97257
出版商
Public Library of Science (PLoS)
发表日期
2014-05-15
DOI
10.1371/journal.pone.0097257
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo
- (2014) C Korin Bullen et al. NATURE MEDICINE
- CD25 and CD69 induction by α4β1 outside-in signalling requires TCR early signalling complex proteins
- (2013) Ann-Marie Cimo et al. BIOCHEMICAL JOURNAL
- CTIP2 is a negative regulator of P-TEFb
- (2013) T. Cherrier et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- 14-Step Synthesis of (+)-Ingenol from (+)-3-Carene
- (2013) L. Jorgensen et al. SCIENCE
- HIV Latency
- (2013) R. F. Siliciano et al. Cold Spring Harbor Perspectives in Medicine
- An In-Depth Comparison of Latent HIV-1 Reactivation in Multiple Cell Model Systems and Resting CD4+ T Cells from Aviremic Patients
- (2013) Celsa A. Spina et al. PLoS Pathogens
- Long-term Follow-up Study of Ingenol Mebutate Gel for the Treatment of Actinic Keratoses
- (2013) Mark Lebwohl et al. JAMA Dermatology
- Histone methyltransferase inhibitors induce HIV-1 recovery in resting CD4+ T cells from HIV-1-infected HAART-treated patients
- (2012) Sophie Bouchat et al. AIDS
- Activation of Latent HIV-1 Expression by Protein Kinase C Agonists. A Novel Therapeutic Approach to Eradicate HIV-1 Reservoirs
- (2012) Gonzalo Sanchez-Duffhues et al. CURRENT DRUG TARGETS
- The role of cytokines in the establishment, persistence and eradication of the HIV reservoir
- (2012) Claire Vandergeeten et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Targeting HIV latency: pharmacologic strategies toward eradication
- (2012) Sifei Xing et al. DRUG DISCOVERY TODAY
- Redefining the Viral Reservoirs that Prevent HIV-1 Eradication
- (2012) Evelyn Eisele et al. IMMUNITY
- Latent HIV-1 Infection Occurs in Multiple Subsets of Hematopoietic Progenitor Cells and Is Reversed by NF- B Activation
- (2012) L. A. McNamara et al. JOURNAL OF VIROLOGY
- In VitroPhenotypic Susceptibility of HIV-2 Clinical Isolates to CCR5 Inhibitors
- (2011) Benoit Visseaux et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- De novo assembly of Euphorbia fischeriana root transcriptome identifies prostratin pathway related genes
- (2011) Roberto A Barrero et al. BMC GENOMICS
- Epigenetic Silencing of HIV-1 by the Histone H3 Lysine 27 Methyltransferase Enhancer of Zeste 2
- (2011) J. Friedman et al. JOURNAL OF VIROLOGY
- Picomolar Dichotomous Activity of Gnidimacrin Against HIV-1
- (2011) Li Huang et al. PLoS One
- Design, synthesis, and evaluation of potent bryostatin analogs that modulate PKC translocation selectivity
- (2011) P. A. Wender et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Bryostatin Modulates Latent HIV-1 Infection via PKC and AMPK Signaling but Inhibits Acute Infection in a Receptor Independent Manner
- (2010) Rajeev Mehla et al. PLoS One
- Cell line-dependent variability in HIV activation employing DNMT inhibitors
- (2010) Guerau Fernandez et al. Virology Journal
- The Protein Kinase C Agonist PEP005 (Ingenol 3-Angelate) in the Treatment of Human Cancer: A Balance between Efficacy and Toxicity
- (2010) Elisabeth Ersvaer et al. Toxins
- Long-Lasting Enfuvirtide Carrier Pentasaccharide Conjugates with Potent Anti-Human Immunodeficiency Virus Type 1 Activity
- (2009) T. Huet et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection
- (2009) Jesus F. Salazar-Gonzalez et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Synergistic Activation of HIV-1 Expression by Deacetylase Inhibitors and Prostratin: Implications for Treatment of Latent Infection
- (2009) Sophie Reuse et al. PLoS One
- Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies
- (2009) Laurence Colin et al. Retrovirology
- "Shock and kill" effects of class I-selective histone deacetylase inhibitors in combination with the glutathione synthesis inhibitor buthionine sulfoximine in cell line models for HIV-1 quiescence
- (2009) Andrea Savarino et al. Retrovirology
- Epigenetic Regulation of HIV-1 Latency by Cytosine Methylation
- (2009) Steven E. Kauder et al. PLoS Pathogens
- Hsp90 Inhibition Suppresses Mutant EGFR-T790M Signaling and Overcomes Kinase Inhibitor Resistance
- (2008) T. Shimamura et al. CANCER RESEARCH
- Lytic Granule Loading of CD8+ T Cells Is Required for HIV-Infected Cell Elimination Associated with Immune Control
- (2008) Stephen A. Migueles et al. IMMUNITY
- Practical Synthesis of Prostratin, DPP, and Their Analogs, Adjuvant Leads Against Latent HIV
- (2008) P. A. Wender et al. SCIENCE
- Differential effects of phorbol-13-monoesters on human immunodeficiency virus reactivation
- (2007) Nieves Márquez et al. BIOCHEMICAL PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now